Status:
UNKNOWN
The Research of the Effect of Sevoflurane on Brain-protection of Cardiac Surgery in Infants.
Lead Sponsor:
Jun Ma
Conditions:
Congenital Heart Disease
Infant, Premature, Diseases
Eligibility:
All Genders
Up to 3 years
Phase:
NA
Brief Summary
To observe the effect of sevoflurane on the concentration of S100β and regional cerebral oxygen saturation in infants with congenital heart disease undergoing cardiac surgery.
Eligibility Criteria
Inclusion
- Clinical diagnosis of congenital heart disease
- Undergoing heart surgery with cardiopulmonary bypass
Exclusion
- Pulmonary arterial hypertension
- Sevoflurane allergy
Key Trial Info
Start Date :
January 20 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 28 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03366597
Start Date
January 20 2018
End Date
December 28 2022
Last Update
February 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Anzhen Hospital
Beijing, Beijing Municipality, China, 100038